During the past decade, Carolinas Healthcare System, Center for Liver Disease conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolinas Healthcare System, Center for Liver Disease" #1 sponsor was "Celgene" with 2 trials, followed by "Conatus Pharmaceuticals Inc." with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Genfit" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolinas Healthcare System, Center for Liver Disease" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Carolinas Healthcare System, Center for Liver Disease" are "Hepatitis C" (3 trials), "Crohn Disease" (2 trials), "Decompensated Cirrhosis" (1 trials), "Fibrosis" (1 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "Carolinas Healthcare System, Center for Liver Disease" in a lesser frequency.

Most popular intervention types in "Carolinas Healthcare System, Center for Liver Disease" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Emricasan (5 mg)" (2 trials), "GED-0301" (2 trials), "Elafibranor" (1 trials) and "Emricasan (25 mg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolinas Healthcare System, Center for Liver Disease" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Carolinas Healthcare System, Center for Liver Disease". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Carolinas Healthcare System, Center for Liver Disease, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Carolinas Healthcare System, Center for Liver Disease, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".